Direct lineage reprogramming is the conversion of one specialized cell type to another without the need for a pluripotent intermediate. To date, a wide variety of cell types have been successfully generated using direct reprogramming, both in vitro and in vivo. These newly converted cells have the potential to replace cells that are lost to disease and/or injury. In this chapter, we will focus on direct reprogramming in the central nervous system. We will review current progress in the field with regards to all the major neural cell types and explore how cellular heterogeneity, both in the starter cell and target cell population, may have implications for direct reprogramming. Finally, we will discuss new technologies that will improve our understanding of the reprogramming process and aid the development of more specific and efficient future CNS-based reprogramming strategies.
CITATION STYLE
Bajohr, J., & Faiz, M. (2020). Direct Lineage Reprogramming in the CNS. In Advances in Experimental Medicine and Biology (Vol. 1212, pp. 31–48). Springer. https://doi.org/10.1007/5584_2019_374
Mendeley helps you to discover research relevant for your work.